CD8A and neoplasm: The glucose/NSUN2/TREX2 axis drives tumorigenesis and resistance to PD-L1 immune therapy in immune-competent syngeneic tumor mouse models by suppressing the cGAS/STING pathway, apoptosis, and CD8+ T cell infiltration.